menu

Medical Program: Investigating a Potential Serum Biomarker for Lung Cancer

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Investigating a Potential Serum Biomarker for Lung Cancer

close
Investigating a Potential Serum Biomarker for Lung Cancer
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Since treatment outcomes vary greatly between lung cancer patients—even among those who are diagnosed at the same stages of disease—much research has been devoted to finding biomarkers that identify patients who are most likely to develop metastatic disease.

    Here to walk us through a promising line of research with hopes of adding the first serum biomarker to the fight against non-small cell lung cancer is Dr. Tony Hu, professor and Weatherhead Presidential chair in Biotechnology Innovation at Tulane University Medical School.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Since treatment outcomes vary greatly between lung cancer patients—even among those who are diagnosed at the same stages of disease—much research has been devoted to finding biomarkers that identify patients who are most likely to develop metastatic disease.

    Here to walk us through a promising line of research with hopes of adding the first serum biomarker to the fight against non-small cell lung cancer is Dr. Tony Hu, professor and Weatherhead Presidential chair in Biotechnology Innovation at Tulane University Medical School.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/24/20